Russia successfully complete human trials of COVID-19 vaccine
Published: 10:58 AM, 13 July 2020 Updated: 11:27 AM, 13 July 2020
The world's first clinical trials of coronavirus vaccine on humans in Russia has been successfully completed.
Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology, confirmed the development to Sputnik news.
"Sechenov University has successfully completed tests on volunteers of the world`s first vaccine against coronavirus," adding that the first group of volunteers would be discharged on Wednesday and the second on July 20.
The university began clinical trials of the vaccine produced by Gamalei Institute of Epidemiology and Microbiology in Russia on June 18.
Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University, said that the objective of this stage of the study was to show the vaccine’s safety for human health, which was successfully done.
“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” Lukashev told Sputnik.
The further vaccine development plan is already being determined by the developer’s strategy, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production, Lukashev added.